Keywords: egis, strong, first-half, results, meet, analyst, approval
Egis' strong first-half 2000 results meet with analyst approval
Article | 16 August 2000
Egis of Hungary, the fourth-largest pharmaceutical company in centraland eastern Europe, has reported a strong set of first-half 2000 figures as ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
